Genemarkers provides collaborative services that enhance the utilization of genomics for improving health care, pharmaceutical research and consumer products. We take pride in providing high quality data and customer service. Our strength lies in our flexibility and personalized approach, allowing Genemarkers to meet the unique needs of each of our clients.
Pharmacogenomics (PGX) testing is rapidly emerging in clinical practice as medicine moves from a one-size-fits-all model to a precision medicine approach. PGX testing is used to:
Genemarkers added Mindy S. Goldstein, PhD to its team of scientific consultants. Her 25-plus years of experience in personal care and nutraceutical product development will be an asset to the company’s customer base, it said. [...]
A private donor has awarded Western Michigan University Homer Stryker M.D. School of Medicine a nearly $1.5 million grant to conduct a clinical study evaluating the clinical utility of pharmacogenomic testing in Kalamazoo’s community mental [...]
Dr. Anna Langerveld, Founder and CEO of Genemarkers, has been appointed as a member of the faculty of the new Western Michigan University Homer Stryker M.D. School of Medicine. Appointed at the rank of Research [...]